SCHEMBL30445918

SCHEMBL30445918

O=C1Nc2cc(C(F)(F)F)ccc2C12CCNCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.47
▸ KCNQ3 O43525 1/20 0.43
▸ KCNQ2 O43526 1/20 0.43
▸ KCNQ4 P56696 1/20 0.43
▸ KCNMA1 Q12791 1/20 0.43
▸ KCNQ5 Q9NR82 1/20 0.43
▸ PKM P14618 1/20 0.41
▸ NR3C2 P08235 4/20 0.40
▸ PARP1 P09874 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.39
▸ TDP2 O95551 1/20 0.39
▸ HTR2A P28223 2/20 0.37
▸ HTR2C P28335 2/20 0.37
▸ HTR2B P41595 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ DAO P14920 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30446355 0.88 BACE1 (0.47) BACE1PARP1PARP10TDP2
SCHEMBL20955239 0.80 NR3C2 (0.52) BACE1PKMNR3C2HTR2ACYP3A4
SCHEMBL21626819 0.78 BACE1 (0.51) BACE1NR3C2CYP3A4
SCHEMBL31492452 0.78 PGR (0.49) TDP2DAO
SCHEMBL20955396 0.77 BACE1 (0.50) BACE1PKMNR3C2TDP2
SCHEMBL20955697 0.77 PKM (0.53) BACE1PKMNR3C2HTR2AHTR2C
SCHEMBL16440215 0.77 BACE1 (0.50) BACE1PKMNR3C2HTR2CMEN1
Hydrochloric Acid SCHEMBL16427860 0.76 BACE1 (0.49) BACE1PKMNR3C2HTR2CMEN1
SCHEMBL17027142 0.76 PGR (0.51) TDP2
SCHEMBL31492425 0.76 PGR (0.51) TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4440697-A1 SPIROCYCLIC INHIBITORS OF APOL1 AND METHODS OF USING SAME Vertex Pharmaceuticals Incorporated (US) 2024-10-09 — — EP disclosed
WO-2023101981-A1 SPIROCYCLIC INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-06-08 — — WO disclosed
Send feedback